Lookup NU author(s): Dr Alistair Henderson,
Professor Bernard Golding
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Male CBA mice and male Sprague-Dawley rats were treated by i.p. injection of glycidamide (GA), the presumed genotoxic metabolite of acrylamide (AA). GA was obtained through a new way of synthesis. As an endpoint of chromosome damage, micronucleus (MN) induction in erythrocytes was measured. Hemoglobin (Hb) adducts were used as a measure of in vivo dose of GA. GA induced linear dose-dependent increases in adduct levels in both species. Rats exhibit, compared with mice, 30% higher Hb adduct levels per unit of administered amount of GA. The incremental MN frequencies per administered dose of GA in mice showed a linear-quadratic dose-dependent curve. In the rat no positive dose-response relationship was obtained, probably due to toxic effects to the bone marrow. The main result of this study is the finding that after treatment with synthetic GA the MN frequency per unit of the in vivo dose of GA in the mouse is very similar to that obtained in a previous study, where animals were treated with AA and GA as a metabolite. This equality in potency of GA, whether its in vivo dose is established by injection of synthetic GA or through metabolism of AA, supports the view that GA is the predominant genotoxic factor in AA exposure. © 2002 Elsevier Science B.V. All rights reserved.
Author(s): Paulsson B, Kotova N, Grawe J, Henderson A, Granath F, Golding B, Tornqvist M
Publication type: Article
Publication status: Published
Journal: Mutation Research/Genetic Toxicology and Environmental Mutagenesis
ISSN (print): 1383-5718
ISSN (electronic): 1568-7864
Publisher: Elsevier BV
PubMed id: 12547279
Altmetrics provided by Altmetric